Covid vaccine maker CureVac hopes shot will get EU approval in June

By Holly Ellyatt4 days ago

AD

Key Points

  • Coronavirus vaccine maker CureVac has said it hopes its coronavirus shot will receive European approval in the second quarter.
  • CureVac's CEO Franz-Werner Haas told CNBC Thursday that the vaccine maker was close to finalizing the recruitment for the vaccine's Phase 3 clinical trial.
  • The company hopes that approval of its shot could come not long after, given the urgent need for additional effective coronavirus vaccines.

In this article

  • CVAC

A man pipettes a blue liquid in a laboratory of the biopharmaceutical company Curevac.

Sebastian Gollnow | picture alliance | Getty Images

Coronavirus vaccine maker CureVac has said it hopes its Covid shot will receive European approval in the second quarter.

Continue read on cnbc.com